Seelos Therapeutics Inc
F:NXEN
Seelos Therapeutics Inc
F:NXEN
Price:
0.025
EUR
-90.23%
Market Closed
Market Cap:
€24.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Seelos Therapeutics Inc
F:NXEN
|
US |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
N
|
Norsk Hydro ASA
XMUN:NOH1
|
NO |
|
E
|
EDP Energias de Portugal SA
SWB:EDP
|
PT |
|
Boot Barn Holdings Inc
NYSE:BOOT
|
US |
|
G
|
General Mills Inc
XMUN:GRM
|
US |
|
Spectral Medical Inc
F:SD4
|
CA |
|
W
|
Whitbread PLC
XMUN:WHF4
|
UK |
|
M
|
Marks and Spencer Group PLC
DUS:MA6
|
UK |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
|
LTC Properties Inc
NYSE:LTC
|
US |
|
C
|
Compass Inc
F:91D
|
US |
|
H
|
Healius Ltd
F:PGZ
|
AU |
|
T
|
Tomra Systems ASA
XHAM:TMR
|
NO |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NXEN's stock price target?
Not Available
NXEN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Seelos Therapeutics Inc?
Projected CAGR
263%
263%
Over the last 8 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 2 years is 263%.
